Literature DB >> 10993525

Simple and reliable method of doxycycline determination in human plasma and biological tissues.

B Axisa1, A R Naylor, P R Bell, M M Thompson.   

Abstract

Over recent years there has been a resurgence in the use of doxycycline in clinical practice, which does not depend on its antibacterial properties. This paper describes a method of determination of doxycycline in human plasma and atheromatous tissue using high-performance liquid chromatography (HPLC), and a cheap commercially available extraction system. Doxycycline is extracted in the mobile phase and injected directly into the HPLC system, avoiding time consuming drying up steps. A limit of detection of 0.125 microg/ml of plasma, and a relative standard deviation of 3% was achieved, making the method very reliable and useful for assays within the usual therapeutic range. The method has also been applied to the extraction of a mixture of tetracyclines from plasma and atherma with equal efficacy, making it useful for assays of this class of drugs in veterinary practice and assays of food contaminants.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993525     DOI: 10.1016/s0378-4347(00)00261-9

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  8 in total

1.  Oral doxycycline prevents skin-associated adverse effects induced by injectable collagenase in a rodent model of capsular contracture around silicone implants.

Authors:  Yannick F Diehm; Dimitra Kotsougiani-Fischer; Elena Porst; Valentin Haug; Laura C Siegwart; Daniel Overhoff; Ulrich Kneser; Sebastian Fischer
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

2.  Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline.

Authors:  Liliana B Menalled; Monica Patry; Natalie Ragland; Phillip A S Lowden; Jennifer Goodman; Jennie Minnich; Benjamin Zahasky; Larry Park; Janet Leeds; David Howland; Ethan Signer; Allan J Tobin; Daniela Brunner
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

3.  Sustained-release formulation of doxycycline hyclate for prophylaxis of tick bite infection in a murine model of Lyme borreliosis.

Authors:  N S Zeidner; K S Brandt; E Dadey; M C Dolan; C Happ; J Piesman
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

4.  Doxycycline does not influence established abdominal aortic aneurysms in angiotensin II-infused mice.

Authors:  Xiaojie Xie; Hong Lu; Jessica J Moorleghen; Deborah A Howatt; Debra L Rateri; Lisa A Cassis; Alan Daugherty
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.752

5.  A novel and rapid method to determine doxycycline in human plasma by liquid chromatography tandem mass spectrometry.

Authors:  A Chaitanya Krishna; M Sathiyaraj; R S Saravanan; R Chelladurai; R Vignesh
Journal:  Indian J Pharm Sci       Date:  2012-11       Impact factor: 0.975

6.  Pharmacokinetics and bioavailability of doxycycline in ostriches (Struthio camelus) at two different dose rates.

Authors:  Ehab A Abu-Basha; Nasir M Idkaidek; Tareq M Hantash
Journal:  J Vet Sci       Date:  2006-12       Impact factor: 1.672

7.  Doxycycline stabilizes vulnerable plaque via inhibiting matrix metalloproteinases and attenuating inflammation in rabbits.

Authors:  Mei Dong; Lin Zhong; Wen Qiang Chen; Xiao Ping Ji; Mei Zhang; Yu Xia Zhao; Li Li; Gui Hua Yao; Peng Fei Zhang; Cheng Zhang; Lei Zhang; Yun Zhang
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

8.  Pharmacokinetics of a peroral single dose of two long-acting formulations and an aqueous formulation of doxycycline hyclate in horses.

Authors:  Heidi Zozaya; Lilia Gutierrez; Maria Josefa Bernad; Hector Sumano
Journal:  Acta Vet Scand       Date:  2013-03-08       Impact factor: 1.695

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.